Bioventus, Inc. (BVS)
9.95
-0.67
(-6.31%)
USD |
NASDAQ |
Nov 19, 16:00
9.96
+0.01
(+0.10%)
After-Hours: 20:00
Bioventus Price to Book Value : 2.832 for Nov. 19, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 19, 2026 | 2.832 |
| November 18, 2026 | 3.023 |
| November 17, 2026 | 3.017 |
| November 16, 2026 | 2.977 |
| November 13, 2026 | 3.034 |
| November 12, 2026 | 3.091 |
| November 11, 2026 | 3.128 |
| November 10, 2026 | 3.182 |
| November 09, 2026 | 3.135 |
| November 06, 2026 | 3.02 |
| November 05, 2026 | 3.040 |
| November 04, 2026 | 3.250 |
| November 03, 2026 | 3.115 |
| November 02, 2026 | 3.743 |
| October 30, 2026 | 3.793 |
| October 29, 2026 | 4.232 |
| October 28, 2026 | 4.170 |
| October 27, 2026 | 4.104 |
| October 26, 2026 | 4.190 |
| October 23, 2026 | 4.258 |
| October 22, 2026 | 4.281 |
| October 21, 2026 | 4.053 |
| October 20, 2026 | 3.971 |
| October 19, 2026 | 3.840 |
| October 16, 2026 | 3.786 |
| Date | Value |
|---|---|
| October 15, 2026 | 3.931 |
| October 14, 2026 | 3.843 |
| October 13, 2026 | 3.860 |
| October 12, 2026 | 3.851 |
| October 09, 2026 | 3.719 |
| October 08, 2026 | 3.612 |
| October 07, 2026 | 3.635 |
| October 06, 2026 | 3.729 |
| October 05, 2026 | 3.848 |
| October 02, 2026 | 3.737 |
| October 01, 2026 | 3.828 |
| September 30, 2026 | 3.880 |
| September 29, 2026 | 4.183 |
| September 28, 2026 | 4.189 |
| September 25, 2026 | 4.126 |
| September 24, 2026 | 4.039 |
| September 23, 2026 | 4.066 |
| September 22, 2026 | 4.078 |
| September 21, 2026 | 3.977 |
| September 18, 2026 | 3.857 |
| September 17, 2026 | 3.774 |
| September 16, 2026 | 3.944 |
| September 15, 2026 | 3.884 |
| September 14, 2026 | 3.932 |
| September 11, 2026 | 3.878 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Accuray, Inc. | 0.1193 |
| Orthofix Medical, Inc. | 0.6014 |
| ResMed, Inc. | 5.601 |
| Rockwell Medical, Inc. | 0.7504 |
| Microbot Medical, Inc. | 0.7869 |
Price to Book Value Related Metrics
| PE Ratio | 12.25 |
| PS Ratio | 1.200 |
| PEG Ratio | 0.0189 |
| Price to Free Cash Flow | 8.491 |
| Price | 9.95 |
| Earnings Yield | 8.16% |
| Market Cap | 681.12M |
| PEGY Ratio | 0.0189 |
| Operating PE Ratio | 11.91 |
| Normalized PE Ratio | 11.92 |